 |
 | Services
| |
 |
Aliases & Descriptions for NAT2
(According to
1HGNC,
2Entrez Gene,
3UniProtKB/Swiss-Prot,
4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc
, and/or 7Ensembl,
8miRBase) About This Section
|
| Aliases |
|---|
| AAC2 2, 3, 5 | | EC 2.3.1.5 3 | | NAT-2 3 | | PNAT 2, 3 |
| | | Descriptions |
|---|
| Arylamide acetylase 2 2, 3 | | N-acetyltransferase 2 2 | | N-acetyltransferase 2 (arylamine N-acetyltransferase) 2 | | N-acetyltransferase type 2 3 | | Polymorphic arylamine N-acetyltransferase 3 |
|
| | Search outside databases for aliases for NAT2 genePrevious GC identifers: GC08P018125 GC08P018311 GC08P018259 |
Summaries for NAT2(According to Entrez Gene,
Wikipedia's
Gene Wiki,
UniProtKB/Swiss-Prot,
and/or
UniProtKB/TrEMBL)
About This Section
| EntrezGene summary for NAT2: This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second arylamine N-acetyltransferase gene (NAT1) is located near this gene (NAT2). [provided by RefSeq] UniProtKB/Swiss-Prot: ARY2_HUMAN, P11245Function: Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogensGene Wiki entry for NAT2 (N-acetyltransferase_2) |
Genomic Location for NAT2
(According to
GeneLoc and/or
HGNC, and/or
Entrez Gene (NCBI build 36),
and/or miRBase,
Genomic Views according to
UCSC and
Ensembl,
Transcription factor binding sites according to
SABiosciences) About This Section
| Genomic View: UCSC Golden Path with GeneCards custom track
Transcription factor binding sites upstream to the NAT2 gene 
Entrez Gene cytogenetic band: 8p22 Ensembl cytogenetic band: 8p22 HGNC cytogenetic band: 8p22NAT2 Gene in genomic location: bands according to Ensembl, locations according to
(and/or Entrez Gene and/or Ensembl if different)
 GeneLoc gene densities for chromosome 8 GeneLoc Exon Structure GeneLoc location for GC08P018293:
(about GC identifiers)
Start:
|
18,293,035 bp from pter |
End:
|
18,303,003 bp from pter |
Size:
|
9,969 bases |
Orientation:
|
plus strand |
RefSeq DNA sequence:- NC_000008.9 NT_030737.9
| Proteins for NAT2
(According to
1UniProtKB,
and/or Ensembl,
Phosphorylation sites according to 2Phosphosite,
RefSeq according to NCBI,
PDB rendering according to OCA and/or Proteopedia,
Recombinant Proteins
from Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Enzo Life Sciences,
Abnova,
OriGene and/or,
Abcam,
Biochemical Assays by
Invitrogen,
Millipore,
R&D Systems,
Cell Signaling Technology, and/or
Enzo Life Sciences,
Ontologies according to Gene
Ontology Consortium 01 Apr 2009 and
Entrez Gene,
Antibodies by Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Cell Signaling Technology,
Abcam,
Abnova, and/or
Novus Biologicals)
About This Section
| UniProtKB/Swiss-Prot: ARY2_HUMAN, P11245 (See
protein sequence)Recommended Name: Arylamine N-acetyltransferase 2 Size: 290 amino acids; 33542 Da
Subcellular location: Cytoplasm
PDB structures from and Proteopedia :2PFR (3D)
 
Secondary accessions: O43637 O60654 O60655 Q13146 Q16697 Q2MLE4 Q2MLF5 Q2MLG8 Q2MLJ6 Q2MLK4 Q2MLK6 Q2MLN7 Q6LET4 Q86XS0 Q86XS1 Q96KY8 Q96T64 Q96T65 Q9H220REFSEQ proteins: NP_000006.2
ENSEMBL proteins: ENSP00000286479
Human Recombinant Proteins Browse Origene for full length recombinant human proteins expressed in human HEK293 cells 
2 Gene Ontology (GO) cellular component terms (links to tree view): About this table
Antibodies for NAT2: Assays for NAT2: | Protein
Domains/ Families for NAT2(According to InterPro, ProtoNet,
UniProtKB, and/or BLOCKS,
Sets of similar genes according to GeneDecks)
About This Section
| - Graphical View of Domain Structure for InterPro Entry P11245
ProtoNet protein and cluster: P11245 1 Blocks protein family: IPB004081 Arylamine N-acetyltransferase signature
UniProtKB/Swiss-Prot: ARY2_HUMAN, P11245Similarity: Belongs to the arylamine N-acetyltransferase family | Gene Function for NAT2
(According to MGI Jun 06 2009, UniProtKB,
IUBMB,and/or Genatlas,
shRNA from
OriGene,
Sigma-Aldrich, RNAi from
Sigma-Aldrich,
RNAi Products,
Clones, and
Q-PCR Products
from Invitrogen,
Millipore,
OriGene, and/or
Abnova,
siRNAs from
Applied Biosystems,
SYBR primers from OriGene,
Cell-based Assays from Millipore,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_000015
Applied Biosystems Silencer® siRNAs for NAT2
Sigma-Aldrich siRNA for NAT2  Sigma-Aldrich shRNA for NAT2  Explore Sigma-Aldrich super-pooled esiRNAs 
              OriGene GFP tagged cDNA clone in CMV expression vector: NM_000015                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_000015                                  untagged cDNA clone in CMV expression vector: NM_000015 
Primers: Browse
Quantitative PCR Central at Invitrogen for Q-PCR LUX™ Primers               OriGene genome-wide validated SYBR primer pairs: NM_000015
UniProtKB/Swiss-Prot: ARY2_HUMAN, P11245Function: Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogensCatalytic activity: Acetyl-CoA + an arylamine = CoA + an N-acetylarylamineEnzyme Number (IUBMB): EC 2.3.1.5 Genatlas biochemistry entry for NAT2:arylamine N-acetyltransferase 2,polymorphic,responsible for slow or rapid acetylation of arylamine and hydrazine drugs,putative susceptibility factor in squamous-cell carcinoma of the esophagus,also involved in bladder carcinogenesis and breast cancer2 MGI mutant phenotypes (inferred from 2 alleles ) (MGI details for Nat1):
3 Gene Ontology (GO) molecular function terms (links to tree view): About this table | Pathways & Interactions for NAT2
(Pathways according to Invitrogen
(maps by GeneGo),
Millipore,
Cell Signaling Technology,
Sigma-Aldrich,
KEGG
and/or UniProtKB,
Sets of similar genes according to GeneDecks,
Proteins Network according to
SABiosciences,
Interactions according to 1UniProtKB,
2MINT, and/or
3STRING,
with links to IntAct and
Ensembl,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|
Gene Network CentralTM Interacting Genes and Proteins Network for NAT2 
5/9 Interacting proteins for NAT2 (ENSP000002864793) via UniProtKB, MINT, and/or STRING (see all 9
)About this table
1 Gene Ontology (GO) biological process term (links to tree view): | GO ID | Qualified GO term | Evidence | PubMed IDs |
|---|
| GO:0008152 | metabolic process |
IEA | -- | About this table
|
Drugs & Compounds for NAT2(Chemical Compounds according to UniProtKB, Enzo Life Sciences,
Sigma-Aldrich, Tocris Bioscience, and/or
Novoseek and Drugs according to
Enzo Life Sciences and/or
PharmGKB)
About This Section
|
Browse Tocris compounds for NAT2 10/56 Novoseek chemical compound relationships for NAT2 gene (see all 56
)
| Compound |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| arylamine |
96.79 |
233 |
1996083 (3), 8081359 (3), 2376572 (2), 7995004 (2) (see all 99) |
| afmu |
92.41 |
39 |
10027663 (3), 11393735 (2), 12580991 (2), 1306111 (2) (see all 15) |
| 1-methylxanthine |
88.43 |
33 |
10027663 (3), 12580991 (2), 14747882 (1), 8573631 (1) (see all 14) |
| 1,7-dimethyluric acid |
85.80 |
6 |
10027663 (1), 11393735 (1), 12580991 (1), 17221922 (1) |
| 5-acetylamino-6-amino-3-methyluracil |
85.26 |
11 |
14747882 (1), 8573631 (1), 11393735 (1), 11503005 (1) (see all 5) |
| n-acetylsulfapyridine |
82.53 |
6 |
12186410 (2), 15032315 (2) |
| 2-aminofluorene |
81.40 |
12 |
11337936 (1), 16829624 (1), 8179482 (1), 9571233 (1) (see all 8) |
| n-hydroxy-2-aminofluorene |
79.90 |
4 |
8425184 (2), 8353847 (1) |
| n-hydroxy phip |
79.89 |
5 |
12773763 (2), 12016157 (1) |
| phip |
79.54 |
41 |
15110095 (3), 11158715 (2), 10381774 (2), 7697826 (2) (see all 16) |
About this table
10/10 PharmGKB drug compound relationships for NAT2 gene (see all 10
)About this table
|
Transcripts for NAT2(GenBank/EMBL/DDBJ Accessions according to
Unigene
(Build 219 Homo sapiens; Jun 2 2009) or GenBank, RefSeq according to Entrez Gene,
DOTS (version 10), and/or
AceView,
non coding RNAs according to
RNAdb,
ESTs according to GeneTide,
exon structure from GeneLoc,
alternative splicing isoforms according to ASD and/or
ECgene,
RNAi Products from Invitrogen,
Millipore, and/or
Abnova,
siRNAs from Applied Biosystems,
Sigma-Aldrich,
shRNA from
Sigma-Aldrich,
OriGene,
Tagged/untagged cDNA clones from
OriGene, Expression Assays from Applied Biosystems) About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_000015
Sigma-Aldrich siRNA for NAT2  Sigma-Aldrich shRNA for NAT2  Explore Sigma-Aldrich super-pooled esiRNAs 
Applied Biosystems Silencer® siRNAs: NM_000015 REFSEQ mRNAs for NAT2 gene: NM_000015.2
Applied Biosystems TaqMan ® Gene Expression Assays: NM_000015               OriGene GFP tagged cDNA clone in CMV expression vector: NM_000015                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_000015                                  untagged cDNA clone in CMV expression vector: NM_000015  Additional cDNA sequence: AJ581144.1 AJ581145.1 AJ581146.1 AJ581147.1 BC015878.1 BC067218.1 CR407631.1 D90040.1 D90042.1 2 DOTS entries: DT.312018 DT.121480210 24/27 AceView cDNA sequences (see all 27
):CB161982 AU099534 BC067218 CR407631 AI792606 AI733799 D90042 BG618195 CB161860 NM_000015 BV183942 BG617259 D90040 BC015878 BU624903 AI460128 BV183943 BG563731 BG569293 BV183945 BG568400 BG566307 BG533459 AI262683
highest scoring ESTs for NAT2:AI262683 AI460128 AI733799 AI792606 AU099534 AV658623 AV658656 AV684197 BC015878 BC067218 Unigene Cluster for NAT2: N-acetyltransferase 2 (arylamine N-acetyltransferase) Hs.2 [show with all ESTs]Unigene Representative Sequence: BC067218
GeneLoc Exon Structure
1 Ensembl transcript including schematic representation: ENST00000286479
|
Expression for NAT2
(Experimental results according to
1GeneNote
and GNF BioGPS,
probe sets-to-genes annotations according to
2GeneAnnot ,
3GeneTide ,
Sets of similar genes according to GeneDecks,
Electronic Northern calculations according to data from
UniGene (Build 219 Homo sapiens),
SAGE tags according to
CGAP,
plus additional links to
SOURCE, and/or
GNF
BioGPS, and/or
EXPOLDB, and/or
UniProtKB,
Expression Assays from
Applied Biosystems
)
About This Section
| NAT2 expression in normal and diseased human tissues
Applied Biosystems TaqMan ® Gene Expression Assays for NAT2
1 / 2 / 3 3 probe-sets matching NAT2 gene Data from
(Publications) and GNF BioGPS About these images About these images
CGAP SAGE TAG: CTAGAAAACA
SOURCE GeneReport for Unigene cluster: Hs.2
|
Orthologs for NAT2
(Orthologs according to
1,2HomoloGene (2older version, for species not in 1newer version),
3euGenes,
4SGD
and/or
5MGI Jun 06 2009,
with possible further links to
Flybase
and/or
WormBase,
Gene Trees according to Ensembl)
About This Section
|
Orthologs for NAT2 gene from 3 species
About this table Species with no ortholog for NAT2
ENSEMBL Gene Tree for NAT2 | Paralogs for NAT2(Paralogs according to 1HomoloGene and 2Ensembl, Pseudogenes according to 3Pseudogene.org) About This Section
| Paralogs for NAT2 gene
- NAT12
|
SNPs/Variants for NAT2(According to the
1NCBI SNP Database,
2Ensembl,
3PupaSUITE, and
UniProtKB,
Linkage Disequilibrium by HapMap,
Genotyping Reagents from
Applied Biosystems)
About This Section
|
HapMap Linkage Disequilibrium images for NAT2 (up to first 250kb)
|
Disorders & Mutations for NAT2
(in which this Gene is Involved, According to
OMIM, UniProtKB,
Novoseek, PharmGKB,
Genatlas, GeneTests,
Blood group antigen gene mutations by BGMUT,
HGMD, GAD,
HuGE Navigator,
BCGD,
and/or TGDB.)
About This Section
|
OMIM: 612182 disorders: 243400 UniProtKB/Swiss-Prot: ARY2_HUMAN, P11245
Genetic variations in NAT2 determine N-acetylation polymorphism by a low or high NAT activity in the liver [MIM:243400]. It has been implicated in the action and toxicity of amine-containing drugs, and in the susceptibility to bladder cancer and systemic lupus erythematosus. This isozyme is responsible for this polymorphism10/93 Novoseek disease relationships for NAT2 gene (see all 93
)
| Disease |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| bladder cancer |
75.13 |
173 |
10510890 (8), 15312364 (6), 10917561 (5), 9107426 (5) (see all 61) |
| genetic susceptibility |
61.05 |
19 |
12015038 (2), 12474054 (2), 10698723 (1), 11751440 (1) (see all 12) |
| colorectal cancer |
60.28 |
98 |
17525862 (7), 16434594 (6), 18159984 (6), 9301503 (4) (see all 40) |
| cancer |
57.14 |
150 |
15548945 (5), 10667461 (5), 12351146 (4), 9301503 (4) (see all 82) |
| cancer lung |
43.39 |
80 |
11815396 (5), 17477782 (5), 18706736 (5), 9731715 (4) (see all 25) |
| colon cancer |
42.19 |
27 |
9301503 (3), 9865425 (3), 16827944 (3), 11099063 (2) (see all 12) |
| breast cancer |
39.35 |
135 |
17535831 (6), 11008907 (6), 12708724 (5), 15609332 (5) (see all 38) |
| chromosomal aberrations |
35.58 |
14 |
10207633 (5), 10333536 (1), 10517994 (1), 11535252 (1) (see all 7) |
| lupus erythematosus |
34.77 |
4 |
12611196 (1), 10599336 (1), 9321764 (1) |
| smoking habit |
32.00 |
1 |
15609332 (1) |
About this table
6 PharmGKB disease relationships for NAT2 geneAbout this table
Genatlas disease: NAT2 isoniazid inactivation Human Gene Mutation Database: NAT2 Genetic Association Database: NAT2 Human Genome Epidemiology Navigator: NAT2 (359 documents)
|
Medical News for NAT2(Possibly Related Articles in
Doctor's Guide)
About This Section
| |
Publications for NAT2 (in
PubMed.
Associations of this gene to articles via
1Novoseek,
2HGNC,
3Entrez Gene,
4UniProtKB/Swiss-Prot,
5UniProtKB/TrEMBL,
6GAD, and/or
7PharmGKB)
About This Section
| 10/822 PubMed articles for NAT2 gene (see all 822
):- NAT2 slow acetylator function as a risk indicator for age-related cataract formation. (PubMed id 12724621)1, 3, 7 Meyer D....van Helden P.D. (2003)
- Arylamine N-acetyltransferase type 2 and glutathione S-transferases M1 and T1 polymorphisms in familial adenomatous polyposis. (PubMed id 11773864)1, 3, 7 Lamberti C....Kruse R. (2002)
- Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis. (PubMed id 12235453)1, 3, 7 Pawlik A....Dabrowska-Zamojcin E. (2002)
- [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer] (PubMed id 15312364)1, 3, 6 Hao G.Y....Zhang Y.H. (2004)
- Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls. (PubMed id 11219770)1, 3, 6 Hou S.M....Lambert B. (2001)
- 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility. (PubMed id 15808403)1, 3, 6 Belogubova E.V....Imyanitov E.N. (2005)
- Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. (PubMed id 14648207)1, 3, 6 Tsukino H....Katoh T. (2004)
- Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China? (PubMed id 15770721)1, 3, 6 Zhang X.F....Tang B.M. (2005)
- NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. (PubMed id 16112301)1, 3, 6 Garcia-Closas M....Rothman N. (2005)
- Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. (PubMed id 11751443)1, 3, 6 Le Marchand L....Donlon T. (2001)
|
Search for NAT2
(in PubMed,
OMIM, and NCBI Bookshelf) About This Section
|
|
Genome Databases showing NAT2
(According to
Entrez Gene,
HGNC,
AceView,
euGenes,
Ensembl,
miRBase,
ECgene,
and/or
H-InvDB)
About This Section
|
| Other Databases showing NAT2
(According to HUGE)
About This Section
| -- |
Specialized Databases showing NAT2(According to ATLAS, HORDE, IMGT, MTDB, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL, Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot) About This Section
|
| About This Section
| --
| Services for NAT2(Reagents available from Applied Biosystems, Antibodies and assays by Cell
Signaling Technology, Abcam, Novus Biologicals, Sigma-Aldrich, R&D Systems, Millipore, Abnova, and/or Invitrogen, Clones available from OriGene,and/or Invitrogen, Drugs and/or compounds by Sigma-Aldrich, Enzo Life Sciences, and/or Tocris Bioscience) About This Section
| 
 Products for NAT2:

 | |
 | | | | |
|
 |  |  |
| | Recombinant Proteins (NAT2) | | Antibodies (NAT2) |
| | | Search Tocris compounds for NAT2 |
|
 |
 | | | |
GeneCards Homepage - Last full update: 1 Jul 2009
Incremental update: 13 Oct 2009
|